Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ibuprofen, Preventive Aspirin Therapy May Have “Deleterious” Effect – Study

This article was originally published in The Tan Sheet

Executive Summary

Ibuprofen combined with aspirin therapy for secondary prevention of cardiovascular disease "may be deleterious," researchers say in the Feb. 15 The Lancet

You may also be interested in...



FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection

Ibuprofen 400 mg may interfere with the cardioprotective effect of uncoated low-dose (81 mg) aspirin when they are concomitantly dosed, FDA said in a Sept. 8 science paper

FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection

Ibuprofen 400 mg may interfere with the cardioprotective effect of uncoated low-dose (81 mg) aspirin when they are concomitantly dosed, FDA said in a Sept. 8 science paper

FDA Warns Of Ibuprofen Interference With Aspirin Cardioprotection

Ibuprofen 400 mg may interfere with the cardioprotective effect of uncoated low-dose (81 mg) aspirin when they are concomitantly dosed, FDA said in a Sept. 8 science paper

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS095134

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel